MoonLake Immunotherapeutics (MLTX) Treasury Shares (2021 - 2026)

MoonLake Immunotherapeutics' Treasury Shares history runs 1 years deep, the most recent figure standing at $6202.0 for Q4 2021.

• In Q1 2026, Treasury Shares rose 102.17% year-over-year to $497942.0; the TTM figure through Mar 2026 stood at $497942.0 (up 102.17% YoY), while the FY2025 annual figure was $191526.0, changed N/A from the prior year.
• Treasury Shares was $497942.0 for Q1 2026 at MoonLake Immunotherapeutics, up from $191526.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $2.8 million in Q2 2022 to a low of $191526.0 in Q2 2025.
• Historically, Treasury Shares has averaged $1.3 million across 5 years, with a median of $1.4 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Treasury Shares surged 192.35% in 2023, then sank 91.38% in 2025.
• A 5-year view of Treasury Shares shows it stood at $1.9 million in 2022, then plunged by 67.54% to $630490.0 in 2023, then surged by 252.28% to $2.2 million in 2024, then tumbled by 91.38% to $191526.0 in 2025, then surged by 159.99% to $497942.0 in 2026.
• The last three Treasury Shares figures came in at $497942.0 (Q1 2026), $191526.0 (Q4 2025), and $191526.0 (Q3 2025), per Business Quant data.